関連する実験動画

Updated: Jun 13, 2026

Light Preference Assay to Study Innate and Circadian Regulated Photobehavior in Drosophila Larvae
07:14

Light Preference Assay to Study Innate and Circadian Regulated Photobehavior in Drosophila Larvae

Published on: April 20, 2013

13.1K

セロトニンは,ドロソフィラのオブジェクトの運動検出器の視覚応答を選択的に調節する

David J Bertsch1, Lesly M Palacios Castillo1, Mark A Frye1

  • 1Department of Integrative Biology and Physiology, University of California, Los Angeles, Los Angeles, CA 90025-7239, USA.

bioRxiv : the preprint server for biology
|August 20, 2025
PubMed
まとめ

セロトニン (5-HT) は,特定のニューロン (LC15) の反応を強化し,受容体の発現がこれらの効果を予測しないにもかかわらず,その増強を調節することによって,ドロソフィラの視覚処理を強化する. この神経調節は脳の中央部で起こり 物体検出に影響します

キーワード:
ドロソフィラ神経調節感覚処理セロトニン視覚系

さらに関連する動画

Electrophysiological Method for Recording Intracellular Voltage Responses of Drosophila Photoreceptors and Interneurons to Light Stimuli In Vivo11:42

Electrophysiological Method for Recording Intracellular Voltage Responses of Drosophila Photoreceptors and Interneurons to Light Stimuli In Vivo

Published on: June 19, 2016

19.7K
Tracking Drosophila Larval Behavior in Response to Optogenetic Stimulation of Olfactory Neurons06:49

Tracking Drosophila Larval Behavior in Response to Optogenetic Stimulation of Olfactory Neurons

Published on: March 21, 2018

7.4K

関連する概念動画

Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical, 7TM, or...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...